News brief­ing: No­var­tis hands off NASH drug to biotech col­lab­o­ra­tor, al­so plans to build new Basel pro­duc­tion unit

Af­ter build­ing up its work on NASH, No­var­tis is hand­ing over one of its can­di­dates to Boston Phar­ma­ceu­ti­cals.

The pri­vate …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.